Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001698403 | SCV000726019 | likely benign | not provided | 2020-10-05 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001185272 | SCV000738783 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2016-04-20 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV000632060 | SCV000753163 | likely benign | Marfan syndrome; Familial thoracic aortic aneurysm and aortic dissection | 2024-01-02 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV001185272 | SCV001351447 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2018-12-16 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV001185272 | SCV003838361 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2022-02-17 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV004002576 | SCV004823067 | likely benign | Marfan syndrome | 2023-12-18 | criteria provided, single submitter | clinical testing |